Biotech Netzwerk Sachsen

The fourth annual BIO-Europe Spring® conference is the premier springtime partnering conference for the biotechnology industry. For its 2010 edition, BIO-Europe Spring moves to Barcelona, Spain on March 8–10, 2010.
The conference annually attracts the international “who’s who” from biotech, pharma and finance for three days of high caliber networking. BIO-Europe Spring’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivalled forum for companies across the biotech value chain to meet and do business. Attend BIO-Europe Spring and experience how you can have more partnering meetings in the three days of the conference than in the rest of the year.

Based on attendance at previous events, BIO-Europe Spring 2010 will bring together over 1,500 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in over 6,000 partnering meetings.

Partnering at BIO-Europe Spring is powered by partneringONE®, the leading conference solution for helping life science delegates meet efficiently and effectively. partneringONE has the unique ability to manage the complex interactions between thousands of executives from many different companies.

This sophisticated web-based partnering system enables delegates to screen potential partners, pre-arrange meetings and manage the entire conference partnering process.

Delegates can log in and connect with the conference community, anytime, anywhere.

Contacts:

In the USA
Tom Voigt
2032 Corte del Nogal, Suite 120
Carlsbad, CA 92011, USA
T: +1 760 930 0500
F: +1 760 030 0520
tvoigt@ebdgroup.com

In Europe
Annika Rudat
Frauenstrasse 22
80469 Munich
Germany
T: +49 89 23 88 756 0
F: +49 89 23 88 756 55
arudat@ebdgroup.com

Die Analytica ist alle zwei Jahre internationaler Treffpunkt für Fachleute aus den Bereichen Umwelt-, Lebensmittel- und Industrie-Analytik, Biochemie, Biotechnologie, Gentechnologie, Molekular- und Zellbiologie, Medizinische Diagnostik und Pharmakologie. Als europäische Kongressmesse dieser Art führt sie regelmäßig Wissenschaftler, Industrie und Anwender zusammen.

Thema: Lebensmittel, Ernährung und Gesundheit

Dieser Kongress zielt auf die Lebensmittelindustrie, Laboratorien und Technologiezentren ab, die sich mit Lebensmitteln und Ernährung beschäftigen. Das Highlight dieser Veranstaltung, verglichen zu anderen Kongressen mit ähnlichen Schwerpunkten, ist der sensorische Ansatz (Geschmack, Aroma, Textur).

Alle Erstinformationen sowie Anmeldeformulare finden Sie unter http://www.taste-nutrition-health.com/.

Neben verschiedenen Veranstaltungen mit wissenschaftlichen Vorträgen internationaler Experten, Diskussionsrunden und praktischen Workshops besteht das Highlight in B2B Meetings. Schwerpunkt ist die Organisation individueller Austauschmöglichkeiten zur Förderung internationaler Kontakte zwischen Lebensmittelunternehmen, Laboratorien und Technologiezentren verschiedener Länder.

Um an den B2B-Meetings teilnehmen zu können ist aus organisatorischen Gründen eine rechtzeitige verbindliche Anmeldung für den Kongress erforderlich.

Weitere Informationen unter http://www.b2match.com/taste-nutrition-health/

Erfahrungen von Biotechnologie-Clustern bei der Standortentwicklung und in internationaler Kooperation

Programm

17:30 Uhr Einlass & Registrierung
18:00 Uhr Eröffnung und Begrüßung, Mario Bauer, Geschäftsführer IHK zu Leipzig
18:10 Uhr BioPharmaNet – Förderung von Life Sciences in der Emilia-Romagna Dott.ssa Cecilia Maini ASTER Scienza Tecnologia Impresa – S.C.p.a., Bologna (Beitrag wird konsekutiv übersetzt)
18:40 Uhr Entwicklungsperspektiven des Biotechnologie-Standorts Sachsen im internationalen Kontext, Dr. Pfister, Direktor, biosaxony
19:00 Uhr Erfahrungen der BIO CITYLeipzig in Standortentwicklung und in internationaler Kooperation Bernhard Faber, Geschäftsführer, BIO-NET Leipzig
19:15 Uhr Ansiedlung eines italienischen Branchen-Unternehmens in Leipzig, Nicola Commisso, Geschäftsführer, InnovaStem GmbH (Beitrag wird konsekutiv übersetzt)
ca. 19:30 Uhr Buffet – individuelle Gespräche und Erfahrungsaustausch

Mehr

Biotechpartnering and Investment in the UK

For the third time, Swiss Equity magazine organizes the Swiss Equity biotech day in cooperation with the Swiss Biotech Association and SIX Swiss Exchange. This get-together of the Swiss biotech industry will include company presentations of listed and privately held companies and reflect current business and science trends.

Ziel der Workshop-Serie ist der Transfer von Entwicklungen innovativer einzelzellbasierter High-Content Analysen z.B. in die klinische Forschung und Diagnostik etc. Der Leipziger Workshop beleuchtet unter anderem die Zytomik, die Systembiologie,  die Zytometrie, neue Verfahren und Reagenzien sowohl in der biologischen und klinischen Anwendung als auch in der Onkologie und Regenerativen Medizin.

Deadlines

- Reduced registration fee Deadline: January 31st, 2010
- Abstract submission Deadline: February 28th, 2010
- Discount Deadline fo r Companies: February 15th, 2010

Referenten (Auswahl)

- Robert F. Murphy, "Identification of Regulated Translocations on a Proteome-scale using Automated Microscopy"
- Frank Preijers, "The pros and cons of flow cytometrical multicolour immunophenotyping"
- Raif Yücel, "Investigating Cellular Signalling using the Advancement of Flow Cytometry"
- Paul J Smith, "Cytometry of models for small cell lung cancer"

Organisation

Prof. Dr. A. Tárnok (Präsident)
Klinik für Kinderkardiologie, Herzzentrum Leipzig GmbH
Universität Leipzig  

Prof. Dr. A. Robitzki
Biotechnologisch-Biomedizinisches  Zentrum (BBZ)
Molekularbiologisch-biochemische Prozesstechnik

Prof. Dr. U. Sack
Institut für Klinische Immunologie und Transfusionsmedizin
Universität Leipzig  

Prof. Dr. F. Emmrich
Institut für Klinische Immunologie und Transfusionsmedizin
Universität Leipzig  

Europäische Messe für Prozesstechnologien in den Bereichen Pharma, Food und Cosmetics.

The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

The event features keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. Past speakers include President George W. Bush, President Bill Clinton, Michael J. Fox, Sir Elton John, Her Majesty Queen Noor of Jordan, and General Colin Powell, among many others. The Convention also features the BIO Business Forum (One-on-One Partnering), hundreds of sessions covering biotech trends, policy issues and technological innovations, and the world's largest biotechnology exhibition – the BIO Exhibition.

Jährlicher Private Equity- und Venture Capital-Branchentreff mit etwa 350 Teilnehmern, auf dem die neuesten Trends, Entwicklungen sowie Praxisbeispiele der Private Equity und VC-Industrie diskutiert werden.

SAC is committed to being a leading organization in supporting the engagement of scientific and clinical communities in their exploration of new areas for cytometry in efforts to advance knowledge and improve human health. The XXV Congress will see the launch in a re-vitalized format for the 2010 and future congresses. The flexible format will allow fresh offerings for delegates, exhibitors and sponsors as we move to yearly meetings and seek links with partnering organizations.

Now in its fifth year, the World Stem Cells and Regenerative Medicine Congress offers three days of the most cutting-edge content in commercial stem cell use.
Industry experts converge to debate and discuss how to overcome the challenges facing regenerative medicine industry today, to open opportunities and business development tomorrow.

5th European Conference on Rare Diseases, Themes of ECRD 2010: National strategies and plans for rare diseases; European Reference Networks and Centres of Expertise for Rare Diseases; Science from the bench to the bed side; Information and Medical Education
The European Committee for Rare Diseases; Policy scenarii for rare diseases; Rare diseases in Central/Eastern Europe, Services to patients, families and carers.

We would like to invite you to the BioForum 2010 – Central European Business Forum of Biotechnology & Innovative BioEconomy, held in Poland, Lodz, May 19-21st, 2010. This is the biggest event for Biotechnology, Pharmacy and Life Science sector in Central Europe.  
It provides a unique platform for finding new business partners in countries like Poland, Czech Republic, Hungary, Estonia, Latvia, Lithuania and Slovakia.

Members of biosaxony network receive 10% discount for trade fairs and BioPartnering.

Meeting focused on the financial health of European biotech.

Conference Topics: Proline Specific Exopeptidases; Prolylendopeptidases; Oxoproline

EuroMedtech™ is the annual medical technology partnering conference that provides unparalleled opportunities for collaboration among medtech decision makers and investors. EuroMedtech attracts companies from all parts of the advanced medical technology industry, including diagnostics, imaging, orthopedics and cardiovascular technologies.
The event features EBD Group’s sophisticated, web-based partnering system, partneringONE®, the life science leading conference networking solution that enables delegates to efficiently mine a large pool of potential partners and pre-arrange private one-to-one meetings. Attending companies range from large multinational medtech companies to emerging start-ups, as well as firms from the financial and service sectors.
EuroMedtech also features 15-minute presentations of medical technology innovations by start-ups and established firms, insightful panel discussions on industry developments and trends, and a lively exhibition.
Join us in Leipzig for the most intensely productive advanced medical technology event of the year.

This congress is organized every second year by the Dresden stem cell community in the newly founded DFG-Research Center for Regenerative Therapies Dresden (CRTD) http://www.crt-dresden.de and the Collaborative Research Center (SFB 655) "Cells into Tissues" http://www.sfb655.de. Based on the experience with our international congresses in 2006 and 2008 we expect about 1000 scientists to attend this exciting meeting from all over the world. In 2010 the congress will focus on stem cells, and the formation of tissues of multiple organs, such as the CNS, pancreas, skin, heart, and the hematopoietic system. In addition, we will specifically address systems biology, biomaterials research, clinical developments in the area of regenerative medicine and cell-based therapies.

Themen:

• Cell death, regeneration and recovery
• Inflammation and stroke
• Imaging and cell tracking in stroke research
• Stem cells and stroke therapy
• Endogenous regeneration – can the brain really cure itself?
• The haunted hedge – why is gliosis so important?
• Regulatory molecules, ncRNA and metabolism – new targets for neuroprotection?
• Mitochondria as cellular targets for protection

Leitung: Dr. Johannes Boltze

Kontakt: Conference Office

event lab.

Klein & Störmer GbR

Talstraße 30

04103 Leipzig

Germany

Phone: +49 (0)341 401 19 36

Fax: +49 (0)341 479 17 80

Seven years ago the WCRM was established first of all as the only event addressing the entire sector of regenerative medicine, providing the one and only complete program for global experts in this field.

This time preventive and regenerative medicine will be combined contributing the synergy between these sectors.

This integration will be fruitful for the future development of both areas, and the World Congress on Preventive & Regenerative Medicine will continue to be the most complete event reflecting the world wide state of the art in preventive and regenerative medicine.